The European Commission has approved Opdivo (nivolumab) monotherapy for an additional indication in advanced renal cell carcinoma (RCC) after prior therapy in adults, announced Bristol-Myers Squibb Company. To demonstrate an overall survival (OS) benefit versus a standard of care in this patient population, Opdivo is the first and only PD-1 immune checkpoint inhibitor approved in Europe. The approval…
As rival Apple Inc readies a renewed push into the world’s fastest-growing market – India, Samsung Electronics Co Ltd is all set to regain its smartphone share in the country with a revamped line-up packed with special features including a safety mode for motorcyclists. Chinese brands as well as local rivals such as Micromax and…
Even as Tesla’s new Model 3 topped 276,000 reservations in a span of just three days, there are questions about whether the customers would be able to get a $7,500 federal tax credit for purchasing the electric car. Many are even skeptical that non availability of federal tax credit for the electric cars could result…
Experts predict that this year could be somewhat tough for Wal-Mart in terms of it generating sales growth. This is attributed to the prediction that as many as 1 million low-income shoppers are about become more tightfisted with their spending as the new qualification requirements rolls into effect for the Supplemental Nutrition Assistance Program in the US.…
Security printing companies like Oberthur Fiduciaire are focusing the most on developing measures that can make banknote counterfeiting almost impossible. Their R&D expenses for this purpose, which central banks from the world over consider a strategic priority, give them a strong case for themselves. But banknotes must not only be secure. They must be meaningful,…
